| J0897 | Injection, denosumab, 1 mg | 7,200 | $20 | $129.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 47,500 | $1 | $95K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 660 | $70 | $44.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 42,000 | $1 | $42K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 1,400 | $20 | $23.8K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 110 | $150 | $15.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 150 | $110 | $15.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 1,430 | $10 | $11.4K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 170 | $70 | $11.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $130 | $9K |